Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Clinicobiological Model Predicting Survival in Medulloblastoma

15 Nov 2004

Abstract excerpt

PURPOSE: The purpose of this study was to determine the relative contributions of biological and clinical predictors of survival in patients with medulloblastoma (MB). EXPERIMENTAL DESIGN: Clinical presentation and survival information were obtained for 119 patients who had undergone surgery for MB at the Hospital for Sick Children (Toronto, Ontario, Canada) between 1985 and 2001. A tissue microarray was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis and VEGF in Cancer
Share to Brain Metastases and Treatment
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15569993
DOI: 10.1158/1078-0432.ccr-04-0499

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Clinicobiological Model Predicting Survival in MedulloblastomaPMID 15569993Read ↗

Combining Gene Expression Profiles and Clinical Parameters for Risk Stratification in MedulloblastomasSemantic proximity Read ↗

Medulloblastoma: what is the role of molecular genetics?Semantic proximity Read ↗

Long-term outcomes by clinical and molecular risk stratification in patients with medulloblastoma receiving risk-adapted therapy.Semantic proximity Read ↗

Medulloblastoma: clinicopathological parameters, risk stratification, and survival analysis of immunohistochemically validated molecular subgroupsSemantic proximity Read ↗

Immunohistochemical Surrogates for Molecular Stratification in Medulloblastoma.Semantic proximity Read ↗

Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort studySemantic proximity Read ↗

Risk factors and risk prediction model for recurrence in medulloblastomaSemantic proximity Read ↗

Histopathological and Molecular Prognostic Markers in MedulloblastomaSemantic proximity Read ↗

Clinical and molecular stratification of disease risk in medulloblastomaSemantic proximity Read ↗

The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials.Semantic proximity Read ↗

Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease.Semantic proximity Read ↗

p53 expression predicts dismal outcome for medulloblastoma patients with metastatic disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.